Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder
CMND•Part A dosing completed in Phase I/II trial
Clearmind Medicine completed treatment for all 24 participants in Part A of its FDA-regulated Phase I/II trial of CMND-100 in alcohol use disorder.
Results have not been presented yet; the dataset is under review.
The company plans to move to the next stage in AUD patients if the data review remains favorable.
